Thread by @TumorBoardTues

No monkeying around!
👨🏻‍⚕️@tompowles1 @drfrankiejs👩🏼‍⚕️may be in UK, but they’re leading #TumorBoardTuesday on Tuesday!

📅03.28.23 at 8pm ET/12am BT
📰1L pembro or Nivo+Cabo?

🐵While case is finalized, collect FREE #CME (AMA & MOC)

🐒integrityce.com/tbt🙊#OncTwitter #RenalCancer

@tompowles1 @drfrankiejs @MPishvaian @minaseconomides @JohnEbbenMDPhD @JineshGheeya @niklas_kluemper @EHeath4100 @Heer_Lab @MariaChiaraMCS @ReisLO @PGrivasMDPhD A tad bit of 🙊monkeying around in #TumorBoardTuesday land by attaching a sneak peak into @JohnEbbenMDPhD's wrap up image. 😉

The info is the same!
📅Tues 03/28/23
🕰️8pm ET/12am BT
☕️Cuppa with🇬🇧@tompowles1 👨🏻‍⚕️👩🏼‍⚕️@drfrankiejs
🗞️1L tx decision for #RenalCancer
#Urology @Uromigos

Join us here on #TumorBoardTuesday for a UK-led #BladderCancer case from👨🏻‍⚕️ @tompowles1👩🏼‍⚕️ @drfrankiejs

📅Tues, 03/28/23 at🕗8PM ET / 12AM 🇬🇧
FREE #CME👉🏽integrityce.com/tbt 👈🏼

💬A way to gather input is with📊, so b4️⃣ their case, tell us where you are in your 🩺 journey
👇🏽

@tompowles1 @drfrankiejs 🐵The above & upcoming #TumorBoardTuesday discussion with moderators @tompowles1 @drfrankiejs is provided by @IntegrityCE

🇬🇧Supported by educational grants from @AstraZeneca, Exelixis, & Merck Sharp & Dohme Corp

🐵More info about our free CME & MOC: integrityce.com/tbt

@tompowles1 @drfrankiejs @IntegrityCE @AstraZeneca 🇬🇧 decided this week was an opportune time to change the clocks!

🕰️We're officially back to 5 hours difference between Eastern Time & British Time

🕰️Have no fear, @tompowles1 @drfrankiejs @BartsECMC are still graciously joining #TumorBoardTuesday at 8pm ET/1:00am BT!!
Join us!

#PreTest Q1️⃣ #TumorBoardTuesday
Free #CME🔗integrityce.com/tbt
LIVE from🇬🇧TONIGHT at 8pm ET/1am BT when @tompowles1 @drfrankiejs join us to chat neoadju #BladderCancer Test your🧠with these❓

🤔What neoadju tx would you pick for 75yo👨🏼‍🦳pT2N1M0 MIBC, HTN, T2DM, 75 mL/min crcl

#PreTest Q2️⃣ #TumorBoardTuesday
#CME🔗 integrityce.com/tbt

🤔What 2L would you pick for your 75yo pt with MIBC & CrCl 45 mL/min with LN progress, new bone mets in the spine, & newly identified FGFR3 alteration after 1L gemcitabine/carboplatin & maintenance avelumab?